Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899665 · ClinicalTrials.gov registry record
Proteases in Patients With Prostate Cancer That Has Spread to the Bone
A clinical trial, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- 31
- Enrollment target
NCT00899665 is a clinical trial that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 31 participants.
The verdict
NCT00899665 has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of bone marrow and tissue from patients to test in the laboratory may help the study of cancer. PURPOSE: This laboratory study is comparing proteases (enzymes that break down protein) in patients with prostate cancer that has spread to the bone with patients who do not have cancer that has spread to the bone.
Interventions
- GENETIC microarray analysis
- OTHER laboratory biomarker analysis
- OTHER immunohistochemistry staining method
- GENETIC fluorescence in situ hybridization
- GENETIC molecular diagnostic method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2001-07 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00899665
The ClinicalTrials.gov registry entry for NCT00899665 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which microarray analysis is the first listed.
NCT00899665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00899665 about?
NCT00899665 is a clinical study titled "Proteases in Patients With Prostate Cancer That Has Spread to the Bone". RATIONALE: Collecting and storing samples of bone marrow and tissue from patients to test in the laboratory may help the study of cancer. PURPOSE: This laboratory study is comparing proteases (enzymes that break down protein) in patients with prostate cancer that has spread to the bone with patient...
What is the current status of trial NCT00899665?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2001-07. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00899665?
The interventions under investigation include: microarray analysis (GENETIC), laboratory biomarker analysis (OTHER), immunohistochemistry staining method (OTHER), fluorescence in situ hybridization (GENETIC), molecular diagnostic method (GENETIC).
Who is sponsoring clinical trial NCT00899665?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.